{"id":72294,"date":"2026-08-11T13:35:51","date_gmt":"2026-08-11T05:35:51","guid":{"rendered":"https:\/\/flcube.com\/?p=72294"},"modified":"2026-08-11T13:35:52","modified_gmt":"2026-08-11T05:35:52","slug":"hangzhou-eli-radiopharma-and-shanghai-smartlogic-sign-strategic-cooperation-agreement-to-advance-computation-driven-radiopharmaceutical-discovery-and-co-build-cyclic-peptide-platform","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=72294","title":{"rendered":"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Hangzhou Eli Radiopharma Co., Ltd.<\/strong> and <strong>Shanghai Smartlogic Technology Ltd.<\/strong> officially signed a <strong>strategic cooperation agreement<\/strong>, the companies announced. The two companies will jointly address key R&amp;D pain points in <strong>radiopharmaceuticals<\/strong>, deepen collaborative innovation in <strong>computation\u2011driven drug discovery<\/strong>, and co\u2011build an <strong>industry\u2011competitive cyclic peptide platform<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-deal-overview\" class=\"wp-block-heading\">Deal Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Parties<\/strong><\/td><td>Hangzhou Eli Radiopharma Co., Ltd. \u00d7 Shanghai Smartlogic Technology Ltd.<\/td><\/tr><tr><td><strong>Deal Type<\/strong><\/td><td>Strategic cooperation agreement<\/td><\/tr><tr><td><strong>Signing Date<\/strong><\/td><td>22 Jul 2026<\/td><\/tr><tr><td><strong>Focus Areas<\/strong><\/td><td>Radiopharmaceutical R&amp;D; computation\u2011driven drug discovery; cyclic peptide platform<\/td><\/tr><tr><td><strong>Strategic Goal<\/strong><\/td><td>Address key R&amp;D pain points in radiopharmaceuticals; co\u2011build an industry\u2011competitive cyclic peptide platform<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-radiopharmaceutical-r-amp-d-efficient-discovery-closed-loop\" class=\"wp-block-heading\">Radiopharmaceutical R&amp;D \u2013 Efficient Discovery Closed Loop<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In radiopharmaceutical R&amp;D, both parties will target:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>High\u2011potential existing pipelines<\/strong><\/li>\n\n\n\n<li><strong>Novel targets<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The collaboration aims to establish an efficient R&amp;D closed loop of:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Computational design \u2192 Synthesis \u2192 Validation \u2192 Optimization<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This closed\u2011loop workflow is designed to accelerate the discovery of <strong>clinical candidates that meet downstream development criteria<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-cyclic-peptide-molecular-resource-platform-co-development\" class=\"wp-block-heading\">Cyclic Peptide Molecular Resource Platform \u2013 Co\u2011Development<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Regarding the co\u2011development of the <strong>cyclic peptide molecular resource platform<\/strong>, the partners will leverage a <strong>&#8220;computation\u2011driven, highly translatable&#8221; physical library of cyclic peptide molecules<\/strong>.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Element<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Foundation<\/strong><\/td><td>Computation\u2011driven, highly translatable physical library of cyclic peptide molecules<\/td><\/tr><tr><td><strong>Approach<\/strong><\/td><td>Collaborative &#8220;computational design \u2013 synthesis \u2013 validation \u2013 iteration&#8221; cycle<\/td><\/tr><tr><td><strong>Objective<\/strong><\/td><td>Build a novel cyclic peptide platform with <strong>independent intellectual property rights<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-strategic-rationale-amp-market-impact\" class=\"wp-block-heading\">Strategic Rationale &amp; Market Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Computation Meets Radiopharma:<\/strong> The partnership pairs <strong>Smartlogic&#8217;s computation\u2011driven drug discovery capabilities<\/strong> with <strong>Eli Radiopharma&#8217;s radiopharmaceutical expertise<\/strong>, directly targeting key R&amp;D pain points in one of oncology&#8217;s fastest\u2011growing modalities.<\/li>\n\n\n\n<li><strong>Closed\u2011Loop Acceleration:<\/strong> The <strong>&#8220;computational design \u2013 synthesis \u2013 validation \u2013 optimization&#8221;<\/strong> closed loop is designed to compress discovery timelines and improve the probability that emerging candidates meet downstream clinical development criteria.<\/li>\n\n\n\n<li><strong>Cyclic Peptide Differentiation:<\/strong> Cyclic peptides occupy a valuable space between small molecules and biologics, offering drug\u2011like properties with expanded target coverage \u2014 a platform asset class with broad partnering potential.<\/li>\n\n\n\n<li><strong>IP Ownership as Strategic Asset:<\/strong> The explicit goal of building a cyclic peptide platform with <strong>independent intellectual property rights<\/strong> signals an intent to create durable, licensable platform value beyond any single program.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the partnership&#8217;s research collaboration, platform development, and candidate discovery outcomes. Actual results may differ due to risks including research execution, intellectual property outcomes, and competitive dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hangzhou Eli Radiopharma Co., Ltd. and Shanghai Smartlogic Technology Ltd. officially signed a strategic cooperation&#8230;<\/p>\n","protected":false},"author":1,"featured_media":72296,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[4877],"class_list":["post-72294","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-eli-radiopharma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Hangzhou Eli Radiopharma Co., Ltd. and Shanghai Smartlogic Technology Ltd. officially signed a strategic cooperation agreement, the companies announced. The two companies will jointly address key R&amp;D pain points in radiopharmaceuticals, deepen collaborative innovation in computation\u2011driven drug discovery, and co\u2011build an industry\u2011competitive cyclic peptide platform.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=72294\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform\" \/>\n<meta property=\"og:description\" content=\"Hangzhou Eli Radiopharma Co., Ltd. and Shanghai Smartlogic Technology Ltd. officially signed a strategic cooperation agreement, the companies announced. The two companies will jointly address key R&amp;D pain points in radiopharmaceuticals, deepen collaborative innovation in computation\u2011driven drug discovery, and co\u2011build an industry\u2011competitive cyclic peptide platform.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=72294\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-11T05:35:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-11T05:35:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1103.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72294#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72294\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform\",\"datePublished\":\"2026-08-11T05:35:51+00:00\",\"dateModified\":\"2026-08-11T05:35:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72294\"},\"wordCount\":423,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72294#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1103.webp\",\"keywords\":[\"ELI Radiopharma\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72294#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72294\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=72294\",\"name\":\"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72294#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72294#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1103.webp\",\"datePublished\":\"2026-08-11T05:35:51+00:00\",\"dateModified\":\"2026-08-11T05:35:52+00:00\",\"description\":\"Hangzhou Eli Radiopharma Co., Ltd. and Shanghai Smartlogic Technology Ltd. officially signed a strategic cooperation agreement, the companies announced. The two companies will jointly address key R&D pain points in radiopharmaceuticals, deepen collaborative innovation in computation\u2011driven drug discovery, and co\u2011build an industry\u2011competitive cyclic peptide platform.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72294#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72294\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72294#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1103.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1103.webp\",\"width\":1080,\"height\":608,\"caption\":\"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72294#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform - Insight, China&#039;s Pharmaceutical Industry","description":"Hangzhou Eli Radiopharma Co., Ltd. and Shanghai Smartlogic Technology Ltd. officially signed a strategic cooperation agreement, the companies announced. The two companies will jointly address key R&D pain points in radiopharmaceuticals, deepen collaborative innovation in computation\u2011driven drug discovery, and co\u2011build an industry\u2011competitive cyclic peptide platform.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=72294","og_locale":"en_US","og_type":"article","og_title":"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform","og_description":"Hangzhou Eli Radiopharma Co., Ltd. and Shanghai Smartlogic Technology Ltd. officially signed a strategic cooperation agreement, the companies announced. The two companies will jointly address key R&D pain points in radiopharmaceuticals, deepen collaborative innovation in computation\u2011driven drug discovery, and co\u2011build an industry\u2011competitive cyclic peptide platform.","og_url":"https:\/\/flcube.com\/?p=72294","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-11T05:35:51+00:00","article_modified_time":"2026-08-11T05:35:52+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1103.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=72294#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=72294"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform","datePublished":"2026-08-11T05:35:51+00:00","dateModified":"2026-08-11T05:35:52+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=72294"},"wordCount":423,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=72294#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1103.webp","keywords":["ELI Radiopharma"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=72294#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=72294","url":"https:\/\/flcube.com\/?p=72294","name":"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=72294#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=72294#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1103.webp","datePublished":"2026-08-11T05:35:51+00:00","dateModified":"2026-08-11T05:35:52+00:00","description":"Hangzhou Eli Radiopharma Co., Ltd. and Shanghai Smartlogic Technology Ltd. officially signed a strategic cooperation agreement, the companies announced. The two companies will jointly address key R&D pain points in radiopharmaceuticals, deepen collaborative innovation in computation\u2011driven drug discovery, and co\u2011build an industry\u2011competitive cyclic peptide platform.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=72294#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=72294"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=72294#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1103.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1103.webp","width":1080,"height":608,"caption":"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=72294#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Hangzhou Eli Radiopharma and Shanghai Smartlogic Sign Strategic Cooperation Agreement to Advance Computation\u2011Driven Radiopharmaceutical Discovery and Co\u2011Build Cyclic Peptide Platform"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1103.webp","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=72294"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72294\/revisions"}],"predecessor-version":[{"id":72297,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72294\/revisions\/72297"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/72296"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=72294"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=72294"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=72294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}